- Role
- Country
- Date of registration
- Address
GB-MF-000001893CE 698580CamAPS FX is an MDD-legacy medical device registered in EUDAMED. It is classified as Class IIb. Manufactured by CamDiab. Placed on the EU market in Germany. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
EUDAMED last updated this device on May 21, 2026
B-G008CAMAPSFX01B8Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
G008CAMAPSFX01B8
DataMatrix generation currently supports GS1-issued UDIs. HIBCC / ICCBBA support is coming.
1 warning recorded — scroll inside the panel to see all entries.
Sterile
A sterile device is supplied free of viable micro-organisms — flagged so that it is handled, stored and used to preserve that sterile state.
Single-use device
A single-use device is intended to be used on one patient during a single procedure and then discarded — not reprocessed or reused.
Contains latex
A "contains latex" flag warns that a device contains natural rubber latex, which can trigger allergic reactions in sensitive patients.
CMR substance
A CMR flag warns that a device contains a substance that is carcinogenic, mutagenic or toxic to reproduction above a defined threshold.
Endocrine-disrupting substance
An endocrine-disruptor flag warns that a device contains a substance with endocrine-disrupting properties above a defined threshold.
Primary placement in Germany; available across 16 countries total.
| Country | On market since | Until |
|---|---|---|
| GermanyPrimary placement | Jun 1, 2021 | Nov 30, 2029 |
| Austria | Jun 1, 2021 | Nov 30, 2029 |
| Belgium | Jun 21, 2022 | Nov 30, 2029 |
| Czechia | Jul 9, 2022 | Nov 30, 2029 |
| Denmark | Jul 9, 2022 | Nov 30, 2029 |
| Spain | Sep 9, 2022 | Nov 30, 2029 |
| Finland | Jul 9, 2022 | Nov 30, 2029 |
| France | May 31, 2021 | Nov 30, 2029 |
| Ireland | Sep 9, 2022 | Nov 30, 2029 |
| Italy | Sep 9, 2022 | Nov 30, 2029 |
| Luxembourg | Jun 1, 2021 | Nov 30, 2029 |
| Netherlands | Jun 21, 2022 | Nov 30, 2029 |
| Norway | May 1, 2024 | Nov 30, 2029 |
| Poland | Sep 9, 2022 | Nov 30, 2029 |
| Sweden | Jul 9, 2022 | Nov 30, 2029 |
| XI | Sep 9, 2022 | Nov 30, 2029 |
Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
G008CAMAPSFX01B8Basic UDI-DI
The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.
B-G008CAMAPSFX01B8UK00003281765UDI issuing entities
Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.
MDR risk classes
MDR risk classes rank medical devices from lowest risk (Class I) to highest (Class III), which determines how much regulatory scrutiny they face.
European Medical Device Nomenclature — the EU product classification assigned to this device.
Z12040282GENERAL MEDICINE THERAPEUTIC TREATMENT INSTRUMENTS - SOFTWARE ACCESSORIESThis device is not currently linked to any other device.
No certificate specifically references this device's Basic UDI-DI.
Certificate health across this manufacturer's portfolio.
MDR 757283SupplementedNotified body
A notified body is an independent organisation, designated by an EU country, that audits manufacturers and certifies higher-risk devices before they can be CE-marked.
View in glossary →